{"id":105365,"date":"2025-10-27T08:11:56","date_gmt":"2025-10-27T13:11:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=105365"},"modified":"2025-10-27T08:41:55","modified_gmt":"2025-10-27T13:41:55","slug":"una-nueva-esperanza-en-la-terapia-dirigida-para-la-histiocitosis","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/es\/new-hope-in-targeted-therapy-for-histiocytosis\/","title":{"rendered":"Nueva esperanza en la terapia dirigida para la histiocitosis"},"content":{"rendered":"<div>\n<p class=\"x_MsoNormal\"><span data-olk-copy-source=\"MessageBody\">Un nuevo estudio de\u00a0<b>Centro Oncol\u00f3gico Memorial Sloan Kettering<\/b>\u00a0destaca el potencial de\u00a0<b>ulixertinib<\/b>, un f\u00e1rmaco de terapia dirigida que bloquea la ERK, para el tratamiento de ciertas formas de\u00a0<b>histiocitosis,<\/b>\u00a0entre otros <b>Enfermedad de Erdheim-Chester (ECD)<\/b>.<\/span><\/p>\n<p class=\"x_MsoNormal\">Dirigida por el Dr. Eli Diamond, miembro del Consejo Asesor M\u00e9dico de la ECDGA, esta investigaci\u00f3n supone un emocionante paso adelante en el tratamiento de los trastornos histioc\u00edticos mediados por la v\u00eda MAPK. Para muchas personas de nuestra comunidad, como Joey, un miembro de la ECDGA cuya trayectoria sigue inspir\u00e1ndonos, estos avances cient\u00edficos representan mucho m\u00e1s que un progreso cl\u00ednico. Ofrecen esperanza.<\/p>\n<p class=\"x_MsoNormal\">Lee la noticia del MSKCC:<br \/>\n<a title=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" href=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"2\">https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood<\/a><\/p>\n<p class=\"x_MsoNormal\">Accede al art\u00edculo t\u00e9cnico completo en <i>C\u00e9lula cancerosa<\/i>:<br \/>\n<a title=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"3\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064<\/a><\/p>\n<p class=\"x_MsoNormal\">En la ECDGA, nos enorgullece apoyar y difundir los trabajos de investigaci\u00f3n que nos acercan a una mejor atenci\u00f3n sanitaria, a m\u00e1s respuestas y, alg\u00fan d\u00eda, a una cura.<\/p>\n<p><em>La Alianza Global contra la Enfermedad de Erdheim-Chester (ECDGA) no ofrece asesoramiento m\u00e9dico, diagn\u00f3sticos ni tratamientos. Todo el contenido tiene car\u00e1cter meramente informativo. Si tiene alguna duda m\u00e9dica, consulte a un profesional sanitario.<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Un nuevo estudio del Memorial Sloan Kettering Cancer Center destaca el potencial del ulixertinib, un f\u00e1rmaco de terapia dirigida que bloquea la ERK, para el tratamiento de ciertas formas de histiocitosis, incluida la enfermedad de Erdheim-Chester (ECD).<\/p>","protected":false},"author":14,"featured_media":105366,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[51],"tags":[375,2599,5100,5103,5107,102,5104,5105,5106,3473,5101,4254,5108,5102,4957],"class_list":["post-105365","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ecdawareness","tag-elidiamond","tag-erdheim-chesterdisease","tag-erkinhibitor","tag-histiocyticdisorders","tag-histiocytosis","tag-mapkpathway","tag-memorialsloankettering","tag-precisionmedicine","tag-rarebloodcancer","tag-rarecancer","tag-rarediseaseresearch","tag-researchbreakthrough","tag-targetedtherapy","tag-ulixertinib"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts\/105365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/comments?post=105365"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts\/105365\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/media\/105366"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/media?parent=105365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/categories?post=105365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/tags?post=105365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}